agilon health, inc. (NYSE:AGL) Receives $4.28 Consensus Target Price from Analysts

Shares of agilon health, inc. (NYSE:AGL - Get Free Report) have been given a consensus recommendation of "Reduce" by the twenty-one research firms that are presently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell rating, sixteen have issued a hold rating and two have issued a buy rating on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $4.28.

AGL has been the subject of a number of recent research reports. Barclays decreased their price objective on agilon health from $5.00 to $2.00 and set an "underweight" rating for the company in a research report on Monday, November 11th. William Blair cut shares of agilon health from an "outperform" rating to a "market perform" rating in a research note on Friday, November 8th. Stifel Nicolaus reduced their target price on shares of agilon health from $7.00 to $2.00 and set a "hold" rating for the company in a research note on Tuesday, November 12th. JMP Securities downgraded shares of agilon health from an "outperform" rating to a "market perform" rating in a report on Monday, November 11th. Finally, TD Cowen cut their price target on shares of agilon health from $6.00 to $2.00 and set a "hold" rating for the company in a report on Monday, November 11th.

agilon health Stock Performance

Shares of agilon health stock traded up $0.06 during trading on Wednesday, reaching $1.91. The company's stock had a trading volume of 1,131,639 shares, compared to its average volume of 4,817,061. The company has a 50-day moving average price of $2.26 and a two-hundred day moving average price of $4.15. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $13.28. The firm has a market cap of $786.95 million, a PE ratio of -2.03 and a beta of 0.51. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same quarter in the prior year, the firm posted ($0.06) earnings per share. On average, analysts forecast that agilon health will post -0.52 EPS for the current year.

Insider Buying and Selling at agilon health

In other news, Director John William Wulf bought 45,000 shares of the business's stock in a transaction that occurred on Thursday, December 5th. The stock was purchased at an average price of $2.18 per share, with a total value of $98,100.00. Following the purchase, the director now owns 206,133 shares of the company's stock, valued at $449,369.94. This trade represents a 27.93 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Diana Mckenzie bought 12,500 shares of agilon health stock in a transaction on Monday, November 25th. The stock was purchased at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the completion of the acquisition, the director now owns 51,319 shares in the company, valued at $117,007.32. This represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 90,000 shares of company stock valued at $198,100 over the last quarter. Corporate insiders own 3.20% of the company's stock.

Hedge Funds Weigh In On agilon health

A number of institutional investors have recently modified their holdings of the company. Point72 Asia Singapore Pte. Ltd. acquired a new position in agilon health in the third quarter valued at $28,000. City State Bank acquired a new stake in shares of agilon health in the third quarter worth approximately $52,000. Allspring Global Investments Holdings LLC grew its holdings in agilon health by 17,790.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company's stock valued at $70,000 after purchasing an additional 10,674 shares during the period. Signaturefd LLC increased its position in agilon health by 166.2% during the second quarter. Signaturefd LLC now owns 11,848 shares of the company's stock worth $77,000 after purchasing an additional 7,398 shares during the last quarter. Finally, CIBC Asset Management Inc purchased a new position in agilon health during the second quarter worth approximately $78,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.